Iranian Journal of Medical Physics

Iranian Journal of Medical Physics

Adaptive Radiotherapy (ART) Using In Vivo Portal Dosimetry Constancy on Halcyon LINAC for Head and Neck Cancer VMAT

Document Type : Original Paper

Authors
Venugopal Sundaram 1
David Khnna 2
Mohandass P 3
Prabhu R 4
Sathyaraj Palanivel 5
Rekha Arya 4
Nilotpal Chakravarty 4
Antovaz S 1
Palanivel D 1
1 Division of Physical Sciences, Karunya Institute of Technology and Sciences, Coimbatore, Tamilnadu, India.
2 Division of Physical Sciences, Karunya Institute of Technology and Sciences, Karunya Nagar, Coimbatore, India- 641 114
3 Department of Radiation Oncology, Fortis Hospital, Mohali, Punjab, India.
4 Department of Radiation Oncology, Yashoda Super Specialty Hospital and Cancer Institute, Sanjay nagar, Ghaziabad, U.P. India.
5 Department of Radiation Oncology, Kidwai memorial institute of oncology center, Bengaluru, India.
10.22038/ijmp.2025.91205.2615
Abstract
Introduction: This study evaluated the potential of the Varian Halcyon LINAC and its associated Portal Dosimetry (PD) software, using in vivo megavoltage portal images, as a tool for in vivo portal dosimetry constancy (IVDc) in head and neck cancer (HNC) patients receiving volumetric modulated arc therapy (VMAT).
Material and Methods: A retrospective study included 100 HNC patients (mean age 58.4 ± 9.2 years; 72 males, 28 females) treated with three arc VMAT plans on the Halcyon LINAC. A prescription dose of 7000 cGy was delivered over 35 fractions to high risk volumes and 6300 cGy to intermediate risk volumes. Portal images from all fractions (3500) and arcs (10,500) were compared to first fraction baselines via gamma analysis with a 3%/2 mm criterion and 95% passing threshold. Phantom tests evaluated sensitivity to thickness changes.
Results: Gamma passing rates exhibited a steady decline over the treatment course (R²=0.9724), with an average 93.9 ± 3.6% passing rate, dropping below 90% after 25 fractions. Failures correlated with thickness variations exceeding 1 cm, which were detected with high accuracy during phantom tests. Pretreatment patient-specific QA yielded 100% pass rates.
Conclusion: This study demonstrates the potential of the Halcyon LINAC's integrated PD system and Varian PD software for IVDc in HNC patients treated with VMAT. The results confirm the feasibility of using in vivo MV portal images acquired on the Halcyon LINAC to assess dose consistency throughout treatment.
Keywords
Head and Neck Neoplasms Radiotherapy Intensity
Modulated Radiotherapy Planning Computer
Assisted
Subjects
  1. Zhang S, Zeng N, Yang J, He J, Zhu F, Liao W, et al. Advancements of radiotherapy for recurrent head and neck cancer in modern era. Radiat Oncol. 2023;18(1):166.
  2. Grégoire V, Langendijk JA, Nuyts S. Advances in radiotherapy for head and neck cancer. J Clin Oncol. 2015;33(29):3277-84.
  3. Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An updated review on head and neck cancer treatment with radiation therapy. Cancers (Basel). 2021;13(19):4912.
  4. Alterio D, Marvaso G, Ferrari A, Volpe S, Orecchia R, Jereczek-Fossa BA. Modern radiotherapy for head and neck cancer. Semin Oncol. 2019;46(3):233-45.
  5. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84(1007):967-96.
  6. Hunte SO, Clark CH, Zyuzikov N, Nisbet A. Volumetric modulated arc therapy (VMAT): a review of clinical outcomes—what is the clinical evidence for the most effective implementation? Br J Radiol. 2022;95(1136):20201289.
  7. Buciuman N, Marcu LG. Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—a systematic review of the literature. Laryngoscope Investig Otolaryngol. 2021;6(5):999-1007.
  8. Buciuman N, Marcu LG. Adaptive radiotherapy in head and neck cancer using volumetric modulated arc therapy. J Pers Med. 2022;12(5):668.
  9. Sreejeev AT, Joseph D, Krishnan AS, Pasricha R, Gupta S, Ahuja R, et al. Weekly assessment of volumetric and dosimetric changes during volumetric modulated arc therapy of locally advanced head and neck carcinoma: implications for adaptive radiation therapy—a prospective study. Head Neck. 2024;46(7):1547-56.
  10. Maheshwari G, Dhanawat A, Kumar HS, Sharma N, Jakhar SL. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer. J Cancer Res Ther. 2020;16(3):600-4.
  11. Burela N, Soni TP, Patni N, Natarajan T. Adaptive intensity-modulated radiotherapy in head-and-neck cancer: a volumetric and dosimetric study. J Cancer Res Ther. 2019;15(3):533-8.
  12. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: recommendations of AAPM Task Group No. 218. Med Phys. 2018;45(4):e53-83.
  13. Bojechko C, Phillips M, Kalet A, Ford EC. A quantification of the effectiveness of EPID dosimetry and software-based plan verification systems in detecting incidents in radiotherapy. Med Phys. 2015;42(9):5363-9.
  14. Min S, Choi YE, Kwak J, Cho B. Practical approach for pretreatment verification of IMRT with flattening filter-free (FFF) beams using Varian portal dosimetry. J Appl Clin Med Phys. 2015;16(1):40-50.
  15. Nailon WH, Welsh D, McDonald K, Burns D, Forsyth J, Cooke G, et al. EPID-based in vivo dosimetry using Dosimetry Check®: overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients. J Appl Clin Med Phys. 2019;20(1):6-16.
  16. Kim H, Huq MS, Lalonde R, Houser CJ, Beriwal S, Heron DE. Early clinical experience with Varian Halcyon V2 linear accelerator: dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments. J Appl Clin Med Phys. 2019;20(11):111-20.
  17. MacDougall ND, Graveling M, Hansen VN, Brownsword K, Morgan A. In vivo dosimetry in UK external beam radiotherapy: current and future usage. Br J Radiol. 2017;90(1072):20160915.
  18. Olaciregui-Ruiz I, Beddar S, Greer P, Jornet N, McCurdy B, Paiva-Fonseca G, et al. In vivo dosimetry in external beam photon radiotherapy: requirements and future directions for research, development, and clinical practice. Phys Imaging Radiat Oncol. 2020;15:108-16.
  19. Mijnheer B, Beddar S, Izewska J, Reft C. In vivo dosimetry in external beam radiotherapy. Med Phys. 2013;40(7):070903.
  20. Gros SA, Xu W, Roeske JC, Choi M, Emami B, Surucu M. A novel surrogate to identify anatomical changes during radiotherapy of head and neck cancer patients. Med Phys. 2017;44(3):924-34.
  21. Esteyrie V, Gleyzolle B, Lusque A, Graff P, Modesto A, Rives M, et al. The GIRAFE phase II trial on MVCT-based volumes of the day and dose of the day addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer. Clin Transl Radiat Oncol. 2019;16:34-9.
  22. Sundaram V, Khanna D, Mohandass P, Vasudeva T. Comparison of Progressive Resolution Optimizer and Photon Optimizer algorithms in RapidArc delivery for head and neck SIB treatments. Rep Pract Oncol Radiother. 2023;28(5):623-35.
  23. Miyasaka R, Cho S, Hiraoka T, Chiba K, Kawachi T, Katayose T, et al. Investigation of Halcyon multileaf collimator model in Eclipse treatment planning system: a focus on the VMAT dose calculation with the Acuros XB algorithm. J Appl Clin Med Phys. 2022;23(3):e13519.
  24. Varian Halcyon Linac. Customer user manual. 2019.
  25. Fogliata A, Cayez R, Garcia R, Khamphan C, Reggiori G, Scorsetti M, et al. Flattening filter free beams from Halcyon linac: evaluation of the profile parameters for quality assurance. Med Phys. 2020;47(8):3669-74.
  26. Gao S, Netherton T, Chetvertkov MA, Li Y, Court LE, Simon WE, et al. Acceptance and verification of the Halcyon-Eclipse linear accelerator-treatment planning system without 3D water scanning system. J Appl Clin Med Phys. 2019;20(10):111-7.
  27. Glide-Hurst CK, Bellon M, Foster R, Altunbas C, Speiser M, Altman M, et al. Commissioning of the Varian TrueBeam linear accelerator: a multi-institutional study. Med Phys. 2013;40(3):031719.
  28. Lim TY, Dragojević I, Hoffman D, Flores-Martinez E, Kim GY. Characterization of the Halcyon™ multileaf collimator system. J Appl Clin Med Phys. 2019;20(4):106-14.
  29. Miyasaka R, Cho S, Hiraoka T, Chiba K, Kawachi T, Katayose T, et al. Investigation of Halcyon multileaf collimator model in Eclipse treatment planning system: a focus on the VMAT dose calculation with the Acuros XB algorithm. J Appl Clin Med Phys. 2022;23(3):e13519.
  30. Jarema T, Aland T. Using the iterative kV CBCT reconstruction on the Varian Halcyon linear accelerator for radiation therapy planning for pelvis patients. Phys Med. 2019;68:112-6.
  31. Cai B, Laugeman E, Mazur TR, Park JC, Henke LE, Kim H, et al. Characterization of a prototype rapid kilovoltage x-ray image guidance system designed for a ring shape radiation therapy unit. Med Phys. 2019;46(3):1355-70.
  32. Aland T, Jarema T, Spalding M, Kairn T, Trapp J. Use of in vivo transit portal images to detect gross inter-fraction patient geometry changes on an O-ring type linear accelerator for pelvis and head-neck patients. Biomed Phys Eng Express. 2021;7(6):065036.
Iranian Journal of Medical Physics
Volume 22, Issue 6 - Serial Number 6
November and December 2025
Pages 430-438

  • Receive Date 15 September 2025
  • Revise Date 27 December 2025
  • Accept Date 28 December 2025